Article
Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli.
Molecular biology and evolution - 1 May 2017
Huseby Douglas L, Pietsch Franziska, Brandis Gerrit, Garoff Linnéa, Tegehall Angelica, Hughes Diarmaid
Abstract excerpt
Ciprofloxacin is an important antibacterial drug targeting Type II topoisomerases, highly active against Gram-negatives including Escherichia coli. The evolution of resistance to ciprofloxacin in E. coli always requires multiple genetic changes, usually including mutations affecting two different drug target genes, gyrA and parC. Resistant mutants selected in vitro or in vivo can have many different mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
